Key Takeaways:
- Twist Bioscience (TWST, Financial) spins off Atlas Data Storage with significant seed funding.
- Analysts forecast a potential 36.96% upside for TWST stock.
- GuruFocus projects a 51.91% upside based on GF Value estimates.
Twist Bioscience (TWST) has recently announced the launch of Atlas Data Storage as an independent entity. This strategic move is designed to propel the advancement of its innovative DNA data storage technology. Under the leadership of CEO Varun Mehta and backed by $155 million in seed funding, Atlas Data Storage is poised to accelerate the commercialization of this groundbreaking technology.
Wall Street Analysts Forecast
In an analysis by 11 Wall Street analysts, the one-year average price target for Twist Bioscience Corp (TWST, Financial) stands at $53.74. The projections range from a high of $65.00 to a low of $45.00. This average target price suggests a promising upside of 36.96% from the current stock price of $39.24. For more in-depth estimates, explore the Twist Bioscience Corp (TWST) Forecast page.
Brokerage Recommendations
The consensus among 13 brokerage firms rates Twist Bioscience Corp's (TWST, Financial) stock as "Outperform," with an average recommendation score of 2.0 on a scale where 1 represents a Strong Buy and 5 indicates a Sell. This aligns with positive sentiment towards the company’s future prospects and market positioning.
GF Value Estimate
According to GuruFocus, the estimated GF Value for Twist Bioscience Corp (TWST, Financial) over the next year is $59.61. This estimation indicates a potential upside of 51.91% from the current share price of $39.24. The GF Value is a proprietary metric by GuruFocus that determines the fair market value of the stock, taking into account historical trading multiples, past business performance, and future growth projections. For additional insights, visit the Twist Bioscience Corp (TWST) Summary page.
